Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark W. Feinberg, M.D.

Co-Author

This page shows the publications co-authored by Mark Feinberg and Peter Libby.
Connection Strength

1.086
  1. Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans. Arterioscler Thromb Vasc Biol. 2021 04; 41(4):1487-1503.
    View in: PubMed
    Score: 0.243
  2. LncRNA VINAS regulates atherosclerosis by modulating NF-?B and MAPK signaling. JCI Insight. 2020 11 05; 5(21).
    View in: PubMed
    Score: 0.238
  3. Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence. Sci Transl Med. 2020 02 19; 12(531).
    View in: PubMed
    Score: 0.227
  4. Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem. 2009 Sep 11; 284(37):24914-24.
    View in: PubMed
    Score: 0.109
  5. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem. 2008 Apr 11; 283(15):9692-703.
    View in: PubMed
    Score: 0.099
  6. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2008 Feb 01; 102(2):218-25.
    View in: PubMed
    Score: 0.097
  7. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res. 2004 Mar 19; 94(5):601-8.
    View in: PubMed
    Score: 0.074
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.